Increasing Sensitivity in Patient-Reported MDS-UPDRS Items for Predicting Medication Initiation in Early PD

Area of Science:

• Neurology
• Clinical Research
• Patient-Reported Outcomes

Background:

• The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts IB and II capture patient experiences in Parkinson's disease (PD).
• These self-reported items offer valuable patient insights into disease progression and treatment needs.

Purpose of the Study:

• To identify the most sensitive combination of MDS-UPDRS Parts IB and II items for predicting dopaminergic therapy initiation.
• To develop a refined tool for assessing early PD patient needs and treatment trajectories.

Main Methods:

• Longitudinal analysis of de novo, untreated PD patients.
• Application of item response theory (IRT) and survival analysis to baseline patient-reported symptoms.
• Evaluation of 20 MDS-UPDRS Parts IB and II items for PD severity discrimination and information content.

Main Results:

• A six-item subset, comprising only Part II items, demonstrated superior predictive accuracy for dopaminergic therapy initiation compared to the full 20-item scale.
• This shortened version, termed "Baseline Outcome Voice," showed a significantly higher C-index (P=0.001).

Conclusions:

• The six-item "Baseline Outcome Voice" scale significantly enhances prediction of dopaminergic treatment initiation in early PD.
• Item response theory modeling effectively refined existing measures to identify key predictive patient-reported items.
• Further validation in diverse populations is recommended.